SHPA congratulates NSW Labor on election win
SHPA congratulates NSW Labor on winning Saturday’s 2023 State Election, at a pivotal time to build the specialised hospital pharmacy workforce in Australia’s most populous state.
SHPA taking action on Closing the Gap and the Voice to Parliament
On Closing The Gap Day 2023, SHPA reiterates its call for action to reduce longstanding inequity in medicines access for Aboriginal and Torres Strait Islander patients receiving Pharmaceutical Benefits Scheme (PBS) medicines from hospitals, and formally declared its support for a First Nations Voice to Parliament.
SHPA welcomes medicines-focused MRFF grants across transitions of care, aged care and pharmacogenomics
Members of SHPA are a driving force behind many newly announced Medical Research Future Fund projects, following Federal Health Minister Mark Butler’s highly-anticipated $382 million announcement across nearly 200 projects, including ten funded under the 2022 Quality, Safety and Effectiveness of Medicine Use and Medicine Intervention by Pharmacists grant opportunity.
SHPA lifts up member voices and embraces equity on International Women's Day
SHPA is embracing equity on International Women's Day (IWD) 2023 and beyond, lifting up the experiences of members who continue to dominate leadership positions in the organisation and advocating for flexible, specialised pharmacy career pathways.
With the patient at the centre, PharmCare 2023 opens
Australia’s newest conference for accredited, onsite aged care and GP pharmacists leading patient centred care is underway, and the SHPA Accredited Pharmacist Directory is now live, as delegates from across healthcare disciplines attending the opening of PharmCare 2023 in Hobart.
Hospital pharmacists support pholcodine recall
SHPA has supported the announcement by the Therapeutic Goods Administration (TGA) to recall pholcodine-containing medicines and remove them from the Australian Register of Therapeutic Goods (ARTG), as a regulatory decision that will improve patient safety and reduce medication-related harm.
New report affirms potential of hospital-initiated meds review pathways
SHPA has entrenched its position as the leading voice on safe medicines management across all-important transitions of care, with senior members publishing expert opinion on barriers and enablers to implementation of hospital-initiated post-discharge medication reviews in Australia.
Hospital expertise can drive pharmacist scope reform
SHPA has welcomed the release of the Strengthening Medicare Taskforce Report, while reiterating that hospital-led expansion of pharmacists’ scope of practice is key to reforming and transforming Australia’s healthcare systems for greater sustainability and improved patient outcomes.
Deprescribing, antimicrobial monitoring and Closing the Gap call lead latest JPPR
The dynamism of Hospital Pharmacy is on display in the latest issue of the Journal of Pharmacy Practice and Research (JPPR) with research including validation of an international approach to pharmacist-led deprescribing in kidney disease and the challenges of antimicrobial surveillance in smaller, regional, and remote health facilities, as well as a call to the profession as Hospital Pharmacists unite to Close the Gap.